Cargando…
Immunotherapy for Breast Cancer Treatment
Breast cancer, as a heterogeneous disease, includes a wide range of pathological and clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and hormone replacement therapy, are mainly associated with poor response and high rate of recurrence. Therefore, more efforts a...
Autores principales: | Simonian, Miganoosh, Haji Ghaffari, Mozhan, Negahdari, Babak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pasteur Institute of Iran
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183391/ https://www.ncbi.nlm.nih.gov/pubmed/33724757 http://dx.doi.org/10.52547/ibj.25.3.140 |
Ejemplares similares
-
An Anti-TAZ Monoclonal Antibody Recognizing Cell Surface Expressed TAZ Protein in Human Tumor Cells
por: Haji Ghaffari, Mozhan, et al.
Publicado: (2023) -
Monoclonal Antibody Against Sortilin Induces Apoptosis in Human Breast Cancer Cells
por: Simonian, Miganoosh, et al.
Publicado: (2022) -
Polymorphism (rs16917496) at the miR-502 Binding Site of the Lysine Methyltransferase 5A (SET8) and Its Correlation with Colorectal Cancer in Iranians
por: Mosallayi, Meysam, et al.
Publicado: (2017) -
Evaluation of miR-21 Inhibition and its Impact on Cancer Susceptibility Candidate 2 Long Noncoding RNA in Colorectal Cancer Cell Line
por: Simonian, Miganoosh, et al.
Publicado: (2018) -
Single nucleotide polymorphism rs696 in miR449a binding site of NFKBIA gene is correlated with risk of colorectal cancer
por: Simonian, Miganoosh, et al.
Publicado: (2018)